Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Mol Cell Endocrinol. 2020 Jan 11;504:110703. doi: 10.1016/j.mce.2020.110703

Figure 3:

Figure 3:

Effects of E2 versus ER Agonist Treatment on Female or Male Hypothalamic Astrocyte Glycogen Phosphorylase (GP) Expression. Data depict mean normalized astrocyte GP O.D. values ± S.E.M. following incubation of female [Panel 3A; p < 0.0001] or male [Panel 3B; p = 0.003] astrocytes with graded E2 concentrations. Panels 3C and 3D show effects of E2 versus selective ER agonist exposure on female [p = 0.02] and male astrocyte [p = 0.005] GP content. *p < 0.05; **p < 0.01; ***p < 0.001.